OUR TEAM
A multidisciplinary team of scientists, pharma executives, and medical experts — building a new model of innovation that is scientific, sustainable, and deeply respectful of cultural heritage.
Daniel Feliciano Ferreira
Founder & ChairmanPharma and startup executive with 25 years of experience introducing complex medications in Latin America and leading scalable ventures. Founder of Indigo Pharma (Netherlands) and Diversa SA (exit).
Ernesto Neumann
Chairman Emeritus
52 years of experience in the global pharmaceutical industry. Former VP LatAm at Merck Serono. Board member of Grupo Farma Brasil and Kybora. Recognized for leading access, licensing, and international expansion programs for highly complex medications.
Flavio Litterio
Leading Partner
Over 25 years of experience in business development. Co-founder of Kovi and former partner at McKinsey. Strategic investor in early and growth-stage startups. Responsible for structuring partnerships, fundraising, and strategic governance at Ayamed.
John Durval
Lead Researcher
PhD in Science with over 25 years of experience in Research & Development. Responsible for the formulation of AYA-1 and technical leadership of the product pipeline. Combines knowledge of plant-based APIs with expertise in pharmacotechnics applied to neuroscience.
Jackeline Barbosa
Chief Medical Officer (CMO)
Medical doctor with a PhD in Medical Sciences (UFRJ) and a Master's degree in Neurology (FMUSP-RP). Researcher at Canapse – National Academic Research Consortium and CABSIN – Brazilian Academic Consortium for Integrative Health. Specialized in research and development of phytotherapeutic medicines (Cornell University).
Director of the Department of Phytotherapy and Medicinal Plants at the Santa Casa de Misericórdia of Rio de Janeiro.
Coordinator of the Technical Chamber of Phytotherapy at CREMERJ.
President of the Brazilian Medical Association of Endocannabinology – AMBCANN.
One of the leading authorities in Brazil on prescription phytotherapeutics.
Scientific and Regulatory Council
Our Scientific and Regulatory Council ensures international vision and compliance at every stage — from formulation to licensing.
Clive Page
Director of the Pulmonary Pharmacology Unit – King's College London.
250+ scientific publications. Gold Medal of the Society of Biology. President-elect of the British Pharmacological Society.
Prof. Umesh Banakar, PhD
Global reference in regulatory development.
Over 900 clinical studies conducted. Founder of SPDS. Expert in pharmaceutical formulations, clinical trials, and intellectual property protection.
Alirio Oliveira
CEO of Master Biotec. Introduced the first hyaluronic acid products for women's and nasal health in Brazil. Over 28 years of regulatory and pharmaceutical experience.
Carlos Sverdloff
CEO of ATCGen.
He has led over 40 clinical studies across all phases. He is a professor at FGV, specializing in Value-Based Healthcare and clinical development strategies.